289
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Event-level analyses of sex-risk and injection-risk behaviors among nonmedical prescription opioid users

, DrPH, , PharmD, PhD, , PhD, , MPH, , PhD, , PhD & , PhD show all
Pages 689-697 | Received 02 Oct 2015, Accepted 31 Mar 2016, Published online: 10 Jun 2016

References

  • Keyes KM, Cerda M, Brady JE, Havens JR, Galea S. Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States. Am J Public Health 2014;104:e52–59.
  • Valdiserri R, Khalsa J, Dan C, Holmberg S, Zibbell J, Holtzman D, Lubran R, Compton W. Confronting the emerging epidemic of HCV infection among young injection drug users. Am J Public Health 2014;104:816–821.
  • Suryaprasad AG, White JZ, Xu F, Eichler BA, Hamilton J, Patel A, Hamdounia SB, et al. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006–2012. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2014;59:1411–1419.
  • Albert S, Brason FW, 2nd, Sanford CK, Dasgupta N, Graham J, Lovette B. Project Lazarus: community-based overdose prevention in rural North Carolina. Pain Medicine (Malden, Mass.) 2011;12:S77–85.
  • Okie S. A flood of opioids, a rising tide of deaths. N Engl J Medicine 2010;363:1981–1985.
  • Young AM, Havens JR, Leukefeld CG. A comparison of rural and urban nonmedical prescription opioid users’ lifetime and recent drug use. Am J Drug Alcohol Abuse 2012;38:220–227.
  • Surratt HL, O’Grady C, Kurtz SP, Stivers Y, Cicero TJ, Dart RC, Chen M. Reductions in prescription opioid diversion following recent legislative interventions in Florida. Pharmacoepidemiol Drug Safety 2014;23:314–320.
  • Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry 2014;71:821–826.
  • Benotsch EG, Martin AM, Koester S, Cejka A, Luckman D. Nonmedical use of prescription drugs and HIV risk behavior in gay and bisexual men. Sexually Transmitted Dis 2011;38:105–110.
  • Kecojevic A, Silva K, Sell RL, Lankenau SE. Prescription drug misuse and sexual risk behaviors among young men who have sex with men (YMSM) in Philadelphia. AIDS Behav 2015;19:847–856.
  • Meade CS, Bevilacqua LA, Moore ED, Griffin ML, Gardin JG, Potter JS, Hatch-Maillette M, Weiss RD. Concurrent substance abuse is associated with sexual risk behavior among adults seeking treatment for prescription opioid dependence. Am J Addict 2014;23:27–33.
  • Mateu-Gelabert P, Guarino H, Jessell L, Teper A. Injection and sexual HIV/HCV risk behaviors associated with nonmedical use of prescription opioids among young adults in New York City. J Subst Abuse Treat. 2015;48:13–20.
  • Ross MW, Williams ML. Sexual behavior and illicit drug use. Annu Rev Sex Res 2001;12:290–310.
  • Scott-Sheldon LA, Carey MP, Vanable PA, Senn TE, Coury-Doniger P, Urban MA. Alcohol consumption, drug use, and condom use among STD clinic patients. J Stud Alcohol Drugs 2009;70:762–770.
  • Zule WA, Costenbader EC, Meyer WJ, Jr., Wechsberg WM. Methamphetamine use and risky sexual behaviors during heterosexual encounters. Sexually Transmitted Dis 2007;34:689–694.
  • Leigh BC. Alcohol and condom use: a meta-analysis of event-level studies. Sexually Transmitted Dis 2002;29:476–482.
  • Vosburgh HW, Mansergh G, Sullivan PS, Purcell DW. A review of the literature on event-level substance use and sexual risk behavior among men who have sex with men. AIDS Behav 2012;16:1394–1410.
  • Zibbell JE, Hart-Malloy R, Barry J, Fan L, Flanigan C. Risk factors for HCV infection among young adults in rural New York who inject prescription opioid analgesics. Am J Public Health 2014;104:2226–2232.
  • DHHS. Hepatitis C virus infection in young persons who inject drugs. February 26–27, 2013 Consultation Report, 2013.
  • Oramasionwu CU, Bailey SC, Moore HN, Oramasionwu CO, Russell AL, Zule WA. Dead space in over-the-counter syringes: the implications for HIV and HCV transmission. Int J Drug Policy 2015; 26:1282–1284
  • Zule WA, Cross HE, Stover J, Pretorius C. Are major reductions in new HIV infections possible with people who inject drugs? The case for low dead-space syringes in highly affected countries. Int J Drug Policy 2013;24:1–7.
  • Zule WA, Ticknor-Stellato KM, Desmond DP, Vogtsberger KN. Evaluation of needle and syringe combinations. J Acquired Immune Deficiency Syndromes Hum Retrovirology 1997;14:294–295.
  • Paintsil E, He H, Peters C, Lindenbach BD, Heimer R. Survival of hepatitis C virus in syringes: implication for transmission among injection drug users. J Infect Dis 2010;202:984–990.
  • Vickerman P, Martin NK, Hickman M. Could low dead-space syringes really reduce HIV transmission to low levels? Int J Drug Policy 2013;24:8–14.
  • Zule WA, Bobashev G. High dead-space syringes and the risk of HIV and HCV infection among injecting drug users. Drug Alcohol Dependence 2009;100:204–213.
  • Walsh N, Verster A, Rodolph M, Akl EA. WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs. Int J Drug Policy 2014;25:363–371.
  • Grund JP, Friedman SR, Stern LS, Jose B, Neaigus A, Curtis R, Des Jarlais DC. Syringe-mediated drug sharing among injecting drug users: patterns, social context and implications for transmission of blood-borne pathogens. Social Sci Med (1982) 1996;42:691–703.
  • Koester S, Glanz J, Baron A. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. AIDS Behav 2005;9:27–39.
  • Jose B, Friedman SR, Neaigus A, Curtis R, Grund JP, Goldstein MF, Ward TP, Des Jarlais DC. Syringe-mediated drug-sharing (backloading): a new risk factor for HIV among injecting drug users. AIDS (London, England) 1993;7:1653–1660.
  • Grund JP, Kaplan CD, Adriaans NF, Blanken P. Drug sharing and HIV transmission risks: the practice of frontloading in the Dutch injecting drug user population. J Psychoact Drugs 1991;23:1–10.
  • Weinhardt LS, Carey MP. Does alcohol lead to sexual risk behavior? findings from event-level research. Annu Rev Sex Res 2000;11:125–157.
  • Compton W, Normand J, Lambert E. Sexual acquisition and transmission of HIV cooperative agreement program (SATHCAP), July 2009: introduction. J Urban Health 2009;86:1–4.
  • Iguchi MY, Ober AJ, Berry SH, Fain T, Heckathorn DD, Gorbach PM, Heimer R, et al. Simultaneous recruitment of drug users and men who have sex with men in the United States and Russia using respondent-driven sampling: sampling methods and implications. J Urban Health 2009;86:5–31.
  • Zule WA, Bobashev GV, Wechsberg WM, Costenbader EC, Coomes CM. Behaviorally bisexual men and their risk behaviors with men and women. J Urban Health 2009;86:48–62.
  • Heckathorn D, Semaan S, Broadhead R, Hughes J. Extensions of respondent-driven sampling: a new approach to the study of injection drug users aged 18–25. AIDS Behav 2002;6:55–67.
  • Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Social Prob 1997;44:174–199.
  • Salganik MJ, Heckathorn DD. Sampling and estimation in hidden populations using respondent‐driven sampling. Sociological Method 2004;34:193–240.
  • Derogatis LR. BSI 18, Brief Symptom Inventory 18: Administration, scoring and procedures manual. NCS Pearson, Incorporated, 2001.
  • Costenbader EC, Zule WA, Coomes CC. Racial differences in acquisition of syringes from pharmacies under conditions of legal but restricted sales. Int J Drug Policy 2010;21:425–428.
  • Oramasionwu CU, Johnson TL, Zule WA, Carda-Auten J, Golin CE. Using pharmacies in a structural intervention to distribute low dead space syringes to reduce HIV and HCV transmission in people who inject drugs. Am J Public Health 2015;105:1066–1071.
  • Kolodny A, Courtwright DT, Hwang CS, Kreiner P, Eadie JL, Clark TW, Alexander GC. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health 2015;36:559–574.
  • Zule WA, Desmond DP, Neff JA. Syringe type and drug injector risk for HIV infection: a case study in Texas. Social Sci Med (1982) 2002;55:1103–1113.
  • Fleckenstein J. Chronic hepatitis C in African Americans and other minority groups. Curr Gastroenterol Rep 2004;6:66–70.
  • Moore RD. Epidemiology of HIV infection in the United States: implications for linkage to care. Clin Infect Dis 2011;52:S208–S213.
  • Metzger DS, Koblin B, Turner C, Navaline H, Valenti F, Holte S, Gross M, et al. Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET vaccine preparedness study protocol team. Am J Epidemiol 2000;152:99–106.
  • Simoes AA, Bastos FI, Moreira RI, Lynch KG, Metzger DS. A randomized trial of audio computer and in-person interview to assess HIV risk among drug and alcohol users in Rio De Janeiro, Brazil. J Subst Abuse Treat 2006;30:237–243.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.